JPH054922A - ヒト・レトロウイルス複製の阻害に有効な医薬の調製のためのキサンチンの使用 - Google Patents

ヒト・レトロウイルス複製の阻害に有効な医薬の調製のためのキサンチンの使用

Info

Publication number
JPH054922A
JPH054922A JP3289900A JP28990091A JPH054922A JP H054922 A JPH054922 A JP H054922A JP 3289900 A JP3289900 A JP 3289900A JP 28990091 A JP28990091 A JP 28990091A JP H054922 A JPH054922 A JP H054922A
Authority
JP
Japan
Prior art keywords
formula
group
xanthine
hiv
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3289900A
Other languages
English (en)
Japanese (ja)
Inventor
Bruce J Dezube
ブルース・ジエイ・デズーベ
Arthur B Pardee
アーサー・ビー・パーデイー
Ruth M Ruprecht
ルート・エム・ループレヒト
William J Novick Jr
ウイリアム・ジエイ・ノビツク・ジユニア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Aventis Pharmaceuticals Inc
Original Assignee
Dana Farber Cancer Institute Inc
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc, Hoechst Roussel Pharmaceuticals Inc filed Critical Dana Farber Cancer Institute Inc
Publication of JPH054922A publication Critical patent/JPH054922A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP3289900A 1990-11-07 1991-11-06 ヒト・レトロウイルス複製の阻害に有効な医薬の調製のためのキサンチンの使用 Pending JPH054922A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61023090A 1990-11-07 1990-11-07
US610230 1990-11-07

Publications (1)

Publication Number Publication Date
JPH054922A true JPH054922A (ja) 1993-01-14

Family

ID=24444220

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3289900A Pending JPH054922A (ja) 1990-11-07 1991-11-06 ヒト・レトロウイルス複製の阻害に有効な医薬の調製のためのキサンチンの使用

Country Status (16)

Country Link
EP (1) EP0484785B1 (enExample)
JP (1) JPH054922A (enExample)
KR (1) KR920009397A (enExample)
AT (1) ATE138266T1 (enExample)
AU (1) AU649278B2 (enExample)
CA (1) CA2055041A1 (enExample)
DE (1) DE69119700T2 (enExample)
DK (1) DK0484785T3 (enExample)
ES (1) ES2087205T3 (enExample)
GR (1) GR3020017T3 (enExample)
HU (1) HUT61468A (enExample)
IE (1) IE913879A1 (enExample)
IL (1) IL99966A0 (enExample)
PT (1) PT99434A (enExample)
TW (1) TW209169B (enExample)
ZA (1) ZA918801B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59304710D1 (de) * 1992-02-22 1997-01-23 Hoechst Ag Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
ES2275400B1 (es) * 2005-04-20 2008-04-01 Universidad Autonoma De Madrid Uso de compuestos agonistas de la actividad tubulina desacetilasa de la proteina hdac6 en la elaboracion de composiciones farmaceuticas, dichas composiciones farmaceuticas y sus aplicaciones en el tratamiento de infecciones virales.
WO2009108383A2 (en) 2008-02-29 2009-09-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2011028835A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
EP2611807A2 (en) 2010-09-01 2013-07-10 Concert Pharmaceuticals Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
MX2014012384A (es) 2012-04-13 2014-11-26 Concert Pharmaceuticals Inc Derivados sustituidos de xantina.
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
CH608236A5 (enExample) * 1974-01-22 1978-12-29 Wuelfing J A Fa
US4663317A (en) * 1984-04-18 1987-05-05 Board Of Regents, University Of Texas System Methods and compositions for treating viral infections
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
GB8610136D0 (en) * 1986-04-25 1986-05-29 Wellcome Found Compounds
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung

Also Published As

Publication number Publication date
CA2055041A1 (en) 1992-05-08
DE69119700T2 (de) 1996-11-07
IE913879A1 (en) 1992-05-20
TW209169B (enExample) 1993-07-11
ZA918801B (en) 1992-12-30
HUT61468A (en) 1993-01-28
AU8699891A (en) 1992-05-14
AU649278B2 (en) 1994-05-19
EP0484785B1 (en) 1996-05-22
DE69119700D1 (de) 1996-06-27
ES2087205T3 (es) 1996-07-16
ATE138266T1 (de) 1996-06-15
EP0484785A2 (en) 1992-05-13
EP0484785A3 (en) 1992-12-16
GR3020017T3 (en) 1996-08-31
KR920009397A (ko) 1992-06-25
PT99434A (pt) 1992-09-30
IL99966A0 (en) 1992-08-18
HU913502D0 (en) 1992-01-28
DK0484785T3 (da) 1996-09-23

Similar Documents

Publication Publication Date Title
EP0277151B1 (en) Novel medicinal use of nucleosides
EP1397957A2 (en) Betulinic acid derivatives and uses therefor
EA015846B1 (ru) 2-[5-бром-4-(4-циклопропилнафталин-1-ил)-4н-[1,2,4]триазол-3-илсульфанил]уксусная кислота и ее метиловый эфир
JPH054922A (ja) ヒト・レトロウイルス複製の阻害に有効な医薬の調製のためのキサンチンの使用
US20140073594A1 (en) Glycomimetic compounds and methods to inhibit infection by hiv
JP2000508662A (ja) 抗新生物薬および抗レトロウイルス薬として有用なアクリドンから誘導された化合物
JPH06100450A (ja) 免疫抑制用のキサンチン類
IE914162A1 (en) Use of xanthines for the preparation of a medicament¹effective for inhibiting the effects of allograft reaction¹in humans
SK50696A3 (en) Flavin and its derivatives as anti-viral agents
CA2014663A1 (en) Use of dipyrido (4,3-b) (3,4-f) indoles for the preparation of drugs useful in the treatment of aids
EP0311107A2 (en) Anti-HIV active 3'-fluoro-purine-2',3'-dideoxyribosides
JP2005508283A (ja) 抗ｔｂ活性を有する新規ファーマコフォアとしてのピラノクマリン化合物
US20040116411A1 (en) Combination HIV therapy including camptothecin
US8513214B2 (en) C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV
WO2002059123A2 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
CN100450487C (zh) 作为细胞增殖拮抗剂和细胞分化诱导剂的逆转录酶非核苷抑制剂
US20020182151A1 (en) Benzoylalkylindolepyridinium componds and pharmaceutical compositions comprising such compounds
US5318979A (en) Method of inhibiting the activity of cryptosporidium parvum
EP0243192A2 (en) Antiviral 8-Phenylxanthines
CN114149449B (zh) 一种炔基偶联的二氟苯氨基吡啶酮hiv整合酶抑制剂、制备方法及用途
JPH11228446A (ja) 抗マラリア剤
JPH11228422A (ja) 抗マラリア剤
WO2018181102A1 (ja) ヌクレオシド誘導体又はその塩、及びそれを含む医薬組成物
US20240082235A1 (en) Method for treating or inhibiting cytomegalovirus infection using small molecules targeting protein phosphatase 1
Meleddu Synthesis of different series of small molecules targeting HIV-1 RT, Candida albicans, MAO and G-Quadruplex